Chidamide combined with traditional chemotherapy for primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma: A case report

BACKGROUND: Traditional chemotherapy has benefited many patients with non-Hodgkin's lymphoma, but results in a very poor response in patients with rare lymphomas or refractory lymphomas. Previous studies have shown that chidamide has potential anti-lymphoma activity and reverses lymphoma cell c...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Zhen-Dong, Yang, Hai-Yan, Zhou, Sheng-Sheng, Wang, Man, Mo, Qin-Li, Huang, Feng-Xiang, Peng, Zhi-Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855196/
https://www.ncbi.nlm.nih.gov/pubmed/35211568
http://dx.doi.org/10.12998/wjcc.v10.i4.1341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855196/
https://www.ncbi.nlm.nih.gov/pubmed/35211568
http://dx.doi.org/10.12998/wjcc.v10.i4.1341

Ejemplares similares